BBK Worldwide Repositions as The Patient Experience Company™ and Unveils New Brand Platform
Patient Recruitment Pioneer Leverages Its Communications and Technological Expertise to Enhance the Clinical Trial Patient Journey
BOSTON, June 25, 2018 /PRNewswire/ — For 35 years, BBK Worldwide has been on the crest of the wave with regard to the development and evolution of the patient recruitment industry. Today, the company announces its new marketplace position as The Patient Experience Company. BBK’s promotion of its trendsetting commitment will be reflected in a redesigned company brand, including logo mark and website (bbkworldwide.com). The website details the services and technology-driven solutions devoted to educating consumers, engaging participants, unburdening sites, and supporting sponsors—the combination of which is essential for a company dedicated to enhancing the patient experience.
“Backed by efficacy data and market research, we’ve encapsulated everything we’ve learned to become The Patient Experience Company,” comments Joan F. Bachenheimer, founding principal and CEO, BBK Worldwide. “A critical component of an experience is ‘choice.’ Our technological platform, combined with our creative communications expertise, makes it possible for us to respond to stated preferences—whether expressed by site staff, patients, caregivers, CRAs, or sponsors—and more specifically, to meet the needs of individuals within those subsets. We are dedicated to the type of support that creates a positive synergistic effect.”
BBK leverages its experiential insights through ongoing Patient Voice and Site Voice initiatives. “Our research shows that even the most compliant of participants may still feel a sense of disenfranchisement,” comments Matt Kibby, principal and president, BBK Worldwide. “Engagement is not the same as experience.”
“Every phone call, office visit, and in-person interaction contributes to the overall participant experience,” explains Bonnie A. Brescia, founding principal and corporate development officer, BBK Worldwide. “Our orientation pays homage to the fact that nothing surpasses attention from medical and nursing providers with regard to creating a positive study experience for a participant. Our products and services are designed to alleviate administrative burden, enabling providers to spend more time with their patients.”
The company has a long history of appreciation for sponsor, CRO, patient, caregiver, and healthcare consumer needs. The Patients to Find the Cure® has been BBK’s tagline since its inception. Delivering the best experience at each key touch point in the patient journey guides BBK’s innovative approach to solving recruitment and engagement challenges.
BBK’s announcement coincides with the Annual Meeting of the Drug Information Association in Boston, June 24–28, 2018. Reporters interested in speaking with BBK can visit booth #1607, or they may contact Elizabeth Gargill by phone at 617-630-5513 or by email at [email protected].
BBK Worldwide (bbkworldwide.com)
BBK Worldwide, now rebranded as The Patient Experience Company, devotes its communication expertise and combination of services and technology-driven solutions to educate consumers, engage participants, unburden sites, and support sponsors—the combination of which is essential for a company dedicated to enhancing the patient experience and advancing the industry’s clinical research and development efforts. One of the few remaining corporately independent and full-service R&D marketing firms, BBK has maintained its position at the forefront of innovation for 35 years. BBK’s commitment to ongoing adaptation and industry breakthroughs is made possible by its patented smart technology TrialCentralNet®. Headquartered near Boston, Mass., BBK has partners and offices across Europe and the Asia-Pacific region.
SOURCE BBK Worldwide
PR Newswire source: